Related Concept Videos
Electrophysiology of Normal Cardiac Rhythm
Cardiac Catheterization III: Left Heart Catheterization
Cardiac Catheterization IV: Nursing Management
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Conduction System of the Heart
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Serial secretoneurin measurement and risk of ventricular arrhythmias and death in patients with left ventricular systolic dysfunction.
Dual vs Single Cardioversion of Atrial Fibrillation in Patients With Obesity: A Randomized Clinical Trial.
Risk of ventricular arrhythmias following implantable cardioverter-defibrillator generator change in patients with recovered ejection fraction: Implications for shared decision-making.
Related Experiment Video
Updated: Mar 14, 2026

Translational Rabbit Model of Chronic Cardiac Pacing
Published on: January 6, 2023
Pacing Without Wires: Leadless Cardiac Pacing.
1Department of Cardiology, Ochsner Clinic Foundation, New Orleans, LA.
Leadless cardiac pacemakers (LCPs) offer a significant advancement in bradycardia therapy, showing favorable safety and efficacy compared to traditional pacemakers. Future leadless systems may enable multichamber pacing, transforming cardiac rhythm management.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10:17Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
Area of Science:
- Cardiology
- Biomedical Engineering
- Medical Devices
Background:
- Over 700,000 pacemakers implanted globally each year, with over 250,000 in the U.S.
- Traditional pacemakers use transvenous leads, a system unchanged for over 50 years.
- Leadless pacing systems eliminate transvenous leads for bradyarrhythmia treatment.
Purpose of the Study:
- To review leadless cardiac pacing (LCP) technologies.
- To assess the efficacy and safety of current LCPs.
- To discuss the future potential of leadless pacing.
Main Methods:
- Discussion of two studied leadless cardiac pacemakers: Nanostim and Micra Transcatheter Pacing System.
- Inclusion of one ultrasound-powered device: WiCS-LV.
- Current LCPs are limited to single-chamber ventricular pacing; dual/multichamber leadless pacing is not yet studied.
Main Results:
- Leadless cardiac pacemakers (LCPs) represent a major advancement in bradycardia therapy.
- Initial studies indicate favorable efficacy and safety for Nanostim and Micra LCPs compared to transvenous pacemakers.
Conclusions:
- LCPs demonstrate promising results, potentially transforming bradyarrhythmia treatment.
- Pending FDA approval, these devices may usher in an era of leadless pacing.
- Future developments aim for leadless single- and multichamber pacing solutions.